Rezo Therapeutics

aid: rezo-therapeutics
name: Rezo Therapeutics
description: 'Rezo Therapeutics is a San Francisco (Mission Bay) biopharmaceutical company spun out of the Quantitative Biosciences
  Institute (QBI) at UCSF, co-founded by Nevan Krogan, that is building a disease-agnostic network-biology drug discovery
  platform. Its "sequence to systems to drugs" approach integrates proteomics, human genetics, structural biology, medicinal
  chemistry, bioinformatics and machine learning to construct comprehensive maps of molecular disease networks and identify
  novel, druggable targets for precision therapeutics, with an initial focus on oncology. The company launched in November
  2022 with a $78M Series A led by SR One, a16z Bio + Health and Norwest Venture Partners, and appointed Derek Hicks as chief
  executive officer in August 2025. Rezo is a therapeutics developer rather than a software vendor: its computational platform
  is internal R&D tooling, and the company publishes no public API, SDK, developer portal or machine-readable contract of
  any kind.'
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://i0.wp.com/rezotx.com/wp-content/uploads/2026/03/cropped-Rezo-Icon-Favicon-1.png?fit=512%2C512&ssl=1
url: https://raw.githubusercontent.com/api-evangelist/rezo-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Oncology
- Proteomics
- Life Sciences
- Precision Medicine
- Artificial Intelligence
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/rezo-therapeutics-domain-security.yml
- type: ContentSignal
  url: well-known/rezo-therapeutics-content-signals.yml
- type: Website
  url: https://rezotx.com/
- type: Blog
  url: https://rezotx.com/news/
- type: PrivacyPolicy
  url: https://rezotx.com/privacy-policy/
- type: TermsOfService
  url: https://rezotx.com/terms-of-use/
- type: About
  url: https://rezotx.com/technology/
- type: Careers
  url: https://rezotx.com/careers/
- type: LinkedIn
  url: https://www.linkedin.com/company/rezotx
- type: Crunchbase
  url: https://www.crunchbase.com/organization/rezo-therapeutics
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 4
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Rezo Therapeutics is a clinical-stage biopharmaceutical company whose entire public web presence is nine WordPress
    pages (home, technology, team, careers, news, investors, privacy, terms, one stub) with no developer, docs, or API section
    anywhere in its sitemap; the only machine-readable surface on rezotx.com is the generic WordPress core and Jetpack /wp-json
    route index that every WordPress.com-hosted site serves, which is site infrastructure and not a product API.
  evidence:
  - url: https://rezotx.com/wp-sitemap-posts-page-1.xml
    status: 200
  - url: https://rezotx.com/openapi.json
    status: 404
  - url: https://rezotx.com/graphql
    status: 404
  - url: https://rezotx.com/llms.txt
    status: 404
  - url: https://rezotx.com/.well-known/agent-card.json
    status: 404
  - url: https://rezotx.com/.well-known/agent.json
    status: 404
  - url: https://rezotx.com/.well-known/security.txt
    status: 404
  - url: https://rezotx.com/.well-known/api-catalog
    status: 404
  - url: https://rezotx.com/robots.txt
    status: 200
  checked: '2026-08-26'